Brainsway Ltd.
BWAY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001505065
No open-market purchases or sales by Brainsway Ltd. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $177.3M in total; ARK Invest is the only superinvestor holding it.
Other share classesBRSYF
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Brainsway Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Brainsway Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Moiseyev Gilad | Chief Technology Officer | 53,098 | Jun 22, 2026 | 1 |
| Roth Yiftach | Chief Scientist | 1,072,305 | Jun 3, 2026 | 1 |
| Mitrany Rayten Michal Ety | Director | 12,500 | May 26, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 15 | 7 daysLate | Moiseyev GiladChief Technology Officer | SSale | −5.00K | – | – | −8.6%53.1K after | |
| Jun 3, 2026 (view filing) | Jun 1-2 | 2 days | Roth YiftachChief Scientist | SSale | −7.00K | – | – | −0.6%1.07M after | 4 lots |
| May 26, 2026 (view filing) | May 25-26 | 1 day | Mitrany Rayten Michal EtyDirector | SSale | −18.0K | – | – | −59.0%12.5K after | 2 lots |